Eubacterium coprostanoligenes alleviates chemotherapy-induced intestinal mucositis by enhancing intestinal mucus barrier
Chemotherapy-induced mucositis represents a severe adverse outcome of cancer treatment, significantly curtailing the efficacy of these treatments and, in some cases, resulting in fatal consequences. Despite identifying intestinal epithelial cell damage as a key factor in chemotherapy-induced mucosit...
Main Authors: | Dongsheng Bai, Jiawei Zhao, Runde Wang, Jiaying Du, Chen Zhou, Chunyang Gu, Yuxiang Wang, Lulu Zhang, Yue Zhao, Na Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383523004975 |
Similar Items
-
The common gut microbe Eubacterium hallii also contributes to intestinal propionate formation
by: Christina eEngels, et al.
Published: (2016-05-01) -
Refining and illuminating acetogenic Eubacterium strains for reclassification and metabolic engineering
by: Maximilian Flaiz, et al.
Published: (2024-01-01) -
Eubacterium rectale is a potential marker of altered gut microbiota in psoriasis and psoriatic arthritis
by: Yue Xiao, et al.
Published: (2024-04-01) -
Lower gut abundance of Eubacterium rectale is linked to COVID-19 mortality
by: Yingzhi Liu, et al.
Published: (2023-09-01) -
Exploitation of a Type 1 Toxin–Antitoxin System as an Inducible Counter-Selective Marker for Genome Editing in the Acetogen <em>Eubacterium limosum</em>
by: James Millard, et al.
Published: (2023-05-01)